Hemoglobin assembly pathway

The hemoglobin assembly pathway is a complex biological process essential for the formation of functional hemoglobin tetramers (α2β2) in red blood cells (PMID: 12066114). This pathway requires the precise coordination of heme biosynthesis and the production of alpha- and beta-globin chains, which are subsequently assembled with the help of molecular chaperones like the Alpha-hemoglobin stabilizing protein (AHSP) (PMID: 12066114). AHSP plays a vital role by binding to free alpha-globin, preventing its precipitation and proteotoxicity until it can pair with beta-globin (PMID: 15131265). Defects in this assembly process, such as mutations affecting globin synthesis or heme production, result in severe anemias, including thalassemias and sickle cell disease (PMID: 23143444). Modern therapeutic strategies target this pathway by inducing the expression of fetal hemoglobin (HbF) to bypass adult globin defects or by using small molecules like Voxelotor to stabilize hemoglobin in its oxygenated state (PMID: 31391330, PMID: 33284593). Additionally, erythroid maturation agents like Luspatercept aim to improve the efficiency of this pathway in patients with ineffective erythropoiesis (PMID: 31914241). Understanding the regulatory mechanisms of hemoglobin assembly is crucial for developing gene-editing and pharmacological treatments for hereditary blood disorders (PMID: 33284593).

Other names

Hemoglobin synthesisGlobin-heme assemblyErythropoiesis-related hemoglobin production

Induction of fetal hemoglobin (HbF) synthesis, stabilization of hemoglobin oxygen affinity, and modulation of erythroid maturation.